Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Savvas Frangos

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Life (Basel, Switzerland)|June 28, 2023
Thyroid Nodules and ObesityElpida Demetriou, Maria Fokou, Savvas Frangos, et al.
Biomedicines|July 29, 2025
Higher Body Mass Index Shows No Evidence of Association with Histopathologic Markers of Aggressiveness in Early-Stage Papillary Thyroid CarcinomaAliki Economides, Demetris Lamnisos, Paris Vogazianos, et al.
Journal of Thyroid Research|May 1, 2020
Lymph Node Metastasis and Extrathyroidal Extension in Papillary Thyroid Microcarcinoma in Cyprus: Suspicious Subcentimeter Nodules Should Undergo FNA When Multifocality is SuspectedChristos Papaioannou, Demetris Lamnisos, Katerina Kyriacou, et al.
Medicina (Kaunas, Lithuania)|June 27, 2025
A Narrative Review of the Odyssey of Thyroid Cancer Diagnosis: Can 99mTc-SESTAMIBI Molecular Imaging Replace Fine Needle Aspiration Biopsy?Ioannis Iakovou, Nikitas Papadopoulos, Paraskevi Exadaktylou, et al.
Hellenic Journal of Nuclear Medicine|August 27, 2024
Real-world applicability of differentiated thyroid cancer guidelinesEvanthia Giannoula, Paraskevi Exadaktylou, Christos Melidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2016
Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patientsSavvas Frangos, Ioannis P Iakovou, Robert J Marlowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2015
Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance studySavvas Frangos, Ioannis P Iakovou, Robert J Marlowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative ProjectCathy S Cutler, Elizabeth Bailey, Vijay Kumar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Life (Basel, Switzerland)|June 28, 2023
Thyroid Nodules and ObesityElpida Demetriou, Maria Fokou, Savvas Frangos, et al.
Biomedicines|July 29, 2025
Higher Body Mass Index Shows No Evidence of Association with Histopathologic Markers of Aggressiveness in Early-Stage Papillary Thyroid CarcinomaAliki Economides, Demetris Lamnisos, Paris Vogazianos, et al.
Journal of Thyroid Research|May 1, 2020
Lymph Node Metastasis and Extrathyroidal Extension in Papillary Thyroid Microcarcinoma in Cyprus: Suspicious Subcentimeter Nodules Should Undergo FNA When Multifocality is SuspectedChristos Papaioannou, Demetris Lamnisos, Katerina Kyriacou, et al.
Medicina (Kaunas, Lithuania)|June 27, 2025
A Narrative Review of the Odyssey of Thyroid Cancer Diagnosis: Can 99mTc-SESTAMIBI Molecular Imaging Replace Fine Needle Aspiration Biopsy?Ioannis Iakovou, Nikitas Papadopoulos, Paraskevi Exadaktylou, et al.
Hellenic Journal of Nuclear Medicine|August 27, 2024
Real-world applicability of differentiated thyroid cancer guidelinesEvanthia Giannoula, Paraskevi Exadaktylou, Christos Melidis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 26, 2016
Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patientsSavvas Frangos, Ioannis P Iakovou, Robert J Marlowe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2015
Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance studySavvas Frangos, Ioannis P Iakovou, Robert J Marlowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 11, 2020
Global Issues of Radiopharmaceutical Access and Availability: A Nuclear Medicine Global Initiative ProjectCathy S Cutler, Elizabeth Bailey, Vijay Kumar, et al.
Pageof 2